QualityStocksNewsBreaks Archives - Page 779 of 1520

TuesdayMay 11, 2021 10:12 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Enters Third White-Label Manufacturing Agreement

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness, beverage and natural products company, has signed a definitive agreement to co-manufacture CBD- and THC-infused beverages for St. Peter’s Drinks. The agreement calls for BevCanna to partner with St. Peter’s to product its international beverage brand, Green Monké, a well-established cannabis beverage brand in the United Kingdom. St. Peter’s Drinks is a Canadian-based craft beverage maker that creates drinks that harness the power of plants. In the announcement, St. Peter’s called BevCanna the ideal partner to bring Green Monké “to life” in Canada; company officials also noted that…

TuesdayMay 11, 2021 10:00 am

QualityStocksNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Participation in Upcoming Canaccord Genuity Virtual Conference

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), operating as Chalice Brands and a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, will be participating in Canaccord Genuity’s 2021 Virtual Cannabis Conference. The one-day conference is scheduled for today, May 11, 2021. GLDFF CEO and president Jeff Yapp, along with executive chairman John Varghese will present during the conference; their live presentation will begin at 3:30 p.m EDT. Canaccord Genuity’s annual global cannabis conference is an investor-focused event designed to create a premier opportunity for global leading players in the cannabis industry to gather together and connect.…

TuesdayMay 11, 2021 9:51 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) CEO Talks Business in Two Video Interviews

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) director and CEO Hugh Rogers was a featured guest on two different video interviews. In both interviews, Rogers shared key information and updates about XPhyto, a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. During his InvestorIntel interview with host Peter Clausi, Rogers mentioned that the company had recently received European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system called Covid-ID Lab, which is now registered within the European Union as a commercial in vitro diagnostic (“CE-IVD”) test. During the interview, Rogers noted that the…

TuesdayMay 11, 2021 9:30 am

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Registered Direct Offering Results in $5.66M

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China, has closed a registered direct offering. The offering, conducted with two institutional investors, comprised the purchase and sale of 6,290,000 BHAT ordinary shares, which were sold for $0.90 per share. The transaction resulted in total gross proceeds of approximately $5.66 million for BHAT, before traditional fees and other estimated offering expenses have been deducted. In addition, the company issued unregistered warrants to the investors to purchase an additional 4,088,500 ordinary shares in a concurrent private placement; those warrants…

MondayMay 10, 2021 2:19 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Continues Vital Role in Dealing with COVID-19

United Medical Equipment (“UME,” “UMEBSNI”) has, from the beginning of the COVID-19 pandemic, been at the forefront of addressing various emerging needs. “The company acted as a trusted senior referral source for senior care living communities such as independent and assisted living, hospice and memory care,” reads a recent article. “UME also supplied personal protective equipment (‘PPE’) with flexible payment options and provided comprehensive telehealth.” These interventions are in addition to supplying FDA-approved COVID-19 rapid test kits. With the United States being far from reaching herd immunity due to such factors as “varying beliefs around vaccinations throughout the country, the…

MondayMay 10, 2021 1:48 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Collaborates to Deliver Innovative Plant-Based Medical Solutions in New Zealand

RYAH Group’s (CSE: RYAH) wholly owned subsidiary, RYAH Medtech Inc., a medical device, data and technology company, today announced its entry into a definitive wholesale supply and distribution agreement with Medical Kiwi Ltd, a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices. The newly formed agreement, executed on April 5, 2021, implies distribution of the RYAH Smart Inhaler and cloud-based data analytics platform in New Zealand. “Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner,…

MondayMay 10, 2021 1:37 pm

QualityStocksNewsBreaks – Why Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is ‘One to Watch’

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a torchbearer blazing a new frontier in American cannabis, adheres to the highest ethical, manufacturing, educational, branding and employment standards available in the industry. “Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multistate operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further,” reads a recent article about the company. “Red…

MondayMay 10, 2021 1:10 pm

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Integrates Cutting-Edge Tech for Faster Throughput, Highest Quality

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) has ordered a state-of-the-art Cosolvent Injection System (“CIS”) from British Columbia-based Vitalis. The investment will make Pure Extracts one of the first companies in the world to receive the system, which will position it for many benefits. The CIS will be an add-on that enhances Vitalis carbon dioxide extraction systems that Pure Extracts already uses in its facilities. “The CIS provides dramatically faster throughput capacities while maintaining the quality of the cannabis and hemp extracts,” reads a recent article. “Furthermore, the Vitalis CIS has been designed to achieve the optimal ethanol…

MondayMay 10, 2021 12:41 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Expanding Sequire with Innovative New Features

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has released its unaudited 2020 results, which show an increase in the demand for its products. SRAX intends to continue enhancing its platform to accommodate this growing need. “SRAX will continue to upgrade Sequire with innovative technological improvements such as its new Shelf Registration feature that allows users to review and track their shelf registration and current shelf availability,” reads a recent article. “As interest in data analytics continues to grow, SRAX ensures that Sequire will adapt to…

MondayMay 10, 2021 12:22 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation Schedule for May Investor Conferences

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that it will participate in a number of virtual conferences for the month of May, including the Diamond Equity Emerging Growth Invitational, the Benzinga Small Cap Conference and the CEO Roadshow Webinar Series. Genprex’s CEO and President Rodney Varner will lead the presentations, which will highlight novel gene therapies for cancer and diabetes and upcoming clinical trials in non-small cell lung cancer (“NSCLC”). An archive of the presentations will be available for a period of time following the conferences…

Site Search

Company Search

Category: QualityStocksNewsBreaks